SEC Filings
Farallon Reports 7.4% Avalo Therapeutics Stake Held Through Its Funds
The investment manager reported shared voting authority over 3,974,000 beneficial shares and certified that it was not seeking control.
Avalo Therapeutics (AVTX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The investment manager reported shared voting authority over 3,974,000 beneficial shares and certified that it was not seeking control.
SEC Filings
The holding covered September 30, 2026, and included shared voting authority over 2,490,708 shares.
SEC Filings
The biotech plans a late-stage abdakibart trial in the first half of 2027; higher operating costs accompanied a narrower quarterly loss.
SEC Filings
The Atlanta manager and its Cayman fund hold 2,803,761 Avalo shares and certify they are not seeking control.